Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy

被引:65
作者
Wang, Chenwei [1 ,2 ]
He, Wei [1 ,2 ]
Yuan, Yichuan [1 ,2 ]
Zhang, Yuanping [1 ,2 ]
Li, Kai [1 ,2 ]
Zou, Ruhai [1 ,3 ]
Liao, Yadi [1 ,2 ]
Liu, Wenwu [1 ,2 ]
Yang, Zhiwen [1 ,2 ]
Zuo, Dinglan [1 ]
Qiu, Jiliang [1 ,2 ]
Zheng, Yun [1 ,2 ]
Li, Binkui [1 ,2 ]
Yuan, Yunfei [1 ,2 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Hepatobiliary Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Ultrasound, Canc Ctr, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
early recurrent hepatocellular carcinoma; inflammation-based prognostic score; prognosis predictor; systemic immune-inflammation index; INDEX PREDICTS; CANCER; RESECTION; IMPACT; RATIO;
D O I
10.1111/liv.14281
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims Inflammation-based prognostic scores, such as the Glasgow Prognostic Score (GPS), modified Glasgow Prognostic Score (mGPS), Prognostic Index (PI), Prognostic Nutritional Index (PNI), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR) and systemic immune-inflammation index (SII), are correlated with the survival of hepatocellular carcinoma (HCC) patients, while remain unclear for recurrent HCC. This study aimed to compare the prognostic value of inflammation-based prognostic scores for post-recurrence survival (PRS) in patients with early recurrent HCC (ErHCC, within 2 years after hepatectomy). Methods A total of 580 patients with ErHCC were enrolled retrospectively. The association between the independent baseline and the time-dependent variables and PRS was evaluated by cox regression. The prediction accuracy of the inflammation-based prognostic scores was assessed by time-dependent receiver operating characteristic (ROC) and Harrell's concordance index (C-index) analyses. Results The GPS, mGPS, PI, PNI, NLR, PLR, LMR and SII were all related to the PRS of ErHCC patients, while only the SII (P < .001) remained an independent predictor for PRS in multivariate analysis (hazard ratio: 1.92, 95% confidence interval: 1.33-2.79). Both the C-index of the SII (0.65) and the areas under the ROC curves showed that the SII score was superior to the other inflammation-based prognostic scores for predicting the PRS of ErHCC patients. Conclusions The SII is a useful prognostic indicator for PRS in patients with ErHCC after hepatectomy and is superior to the other inflammation-based prognostic scores in terms of prognostic ability.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 38 条
[1]   Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma [J].
Cabillic, Florian ;
Corlu, Anne .
GASTROENTEROLOGY, 2016, 151 (04) :607-615
[2]   Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection [J].
Chan, Anthony W. H. ;
Zhong, Jianhong ;
Berhane, Sarah ;
Toyoda, Hidenori ;
Cucchetti, Alessandro ;
Shi, KeQing ;
Tada, Toshifumi ;
Chong, Charing C. N. ;
Xiang, Bang-De ;
Li, Le-Qun ;
Lai, Paul B. S. ;
Mazzaferro, Vincenzo ;
Garcia-Finana, Marta ;
Kudo, Masatoshi ;
Kumada, Takashi ;
Roayaie, Sasan ;
Johnson, Philip J. .
JOURNAL OF HEPATOLOGY, 2018, 69 (06) :1284-1293
[3]   Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma [J].
Chang, Y. ;
An, H. ;
Xu, L. ;
Zhu, Y. ;
Yang, Y. ;
Lin, Z. ;
Xu, J. .
BRITISH JOURNAL OF CANCER, 2015, 113 (04) :626-633
[4]   Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma [J].
Chen, Liping ;
Zhang, Qi ;
Chang, Wenjun ;
Du, Yan ;
Zhang, Hongwei ;
Cao, Guangwen .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) :1977-1987
[5]   Systemic immune-inflammation index in germ-cell tumours [J].
Chovanec, Michal ;
Cierna, Zuzana ;
Miskovska, Viera ;
Machalekova, Katarina ;
Kalavska, Katarina ;
Rejlekova, Katarina ;
Svetlovska, Daniela ;
Macak, Dusan ;
Spanik, Stanislav ;
Kajo, Karol ;
Babal, Pavel ;
De Giorgi, Ugo ;
Mego, Michal ;
Mardiak, Jozef .
BRITISH JOURNAL OF CANCER, 2018, 118 (06) :831-838
[6]   Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma [J].
Chua, Darren W. ;
Koh, Ye Xin ;
Liew, Yi Xin ;
Chan, Chung-Yip ;
Lee, Ser-Yee ;
Cheow, Peng-Chung ;
Chow, Pierce K. ;
Chung, Alexander Y. ;
Ooi, London L. ;
Goh, Brian K. P. .
JOURNAL OF SURGICAL ONCOLOGY, 2018, 118 (08) :1227-1236
[7]   Cancer-related inflammation and treatment effectiveness [J].
Diakos, Connie I. ;
Charles, Kellie A. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
LANCET ONCOLOGY, 2014, 15 (11) :E493-E503
[8]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576
[9]   EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018) [J].
Galle, Peter R. ;
Forner, Alejandro ;
Llovet, Josep M. ;
Mazzaferro, Vincenzo ;
Piscaglia, Fabio ;
Raoul, Jean-Luc ;
Schirmacher, Peter ;
Vilgrain, Valerie .
JOURNAL OF HEPATOLOGY, 2019, 70 (04) :817-817
[10]   Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer [J].
Forrest, LM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Dunlop, DJ .
BRITISH JOURNAL OF CANCER, 2004, 90 (09) :1704-1706